Adverse drug reactions associated with COVID-19 management
Crossref DOI link: https://doi.org/10.1007/s00210-024-03137-0
Published Online: 2024-05-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chavda, Vivek
Dodiya, Payal
Apostolopoulos, Vasso
Text and Data Mining valid from 2024-05-14
Version of Record valid from 2024-05-14
Article History
Received: 9 January 2024
Accepted: 30 April 2024
First Online: 14 May 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.